Recording of webcast from Capital Markets Update 2024

Thor Medical ASA held its Capital Markets Update for investors, analysts, financial media and other stakeholders on November 25th.

The event was held at Carnegie's premises in Stockholm, Sweden. You can watch a recording of the presentation and Q&A session in the link below:

‍

‍

Agenda:

Introduction – Jasper Kurth, CEO | Thor Medical
Targeted Alpha Therapies in Cancer Treatment – Professor Jane Sosabowski, PhD | Barts Cancer Institute Queen Mary University of London
Role of Isotope Supply for Targeted Alpha Therapies – Emanuele Ostuni, PhD, CEO | ARTBIO
Thor Medical enabling next-generation precision cancer treatments – Jasper Kurth CEO and Brede Ellingsæter, CFO | Thor Medical

‍

Home